首页> 中文期刊> 《中国生化药物杂志》 >糖皮质激素治疗特发性间质性肺炎后经高分辨率CT半定量分值判断其近期疗效的临床分析

糖皮质激素治疗特发性间质性肺炎后经高分辨率CT半定量分值判断其近期疗效的临床分析

         

摘要

目的 探讨高分辨率CT半定量分值对特发性间质性肺炎患者应用糖皮质激素治疗的近期疗效判断效果.方法 32例特发性间质性肺炎患者均接受常规治疗联合糖皮质激素,利用高分辨率CT半定量分值检查对其近期疗效给予准确判断.结果 经分析可知高分辨率CT半定量分值在20%以下的特发性间质性肺炎患者住院期间病死率为5.26%,而经高分辨率CT半定量分值在20%及以上的患者住院期间病死率高达38.46%,数据对比差异具有统计学意义(P<0.05).结论 应用高分辨率CT半定量分值可对接受糖皮质激素治疗的特发性间质性肺炎患者近期疗效给予准确判断,对医师制定今后药物治疗方案并保障其预后具有积极意义.%Objective To evaluate the short-term effect of glucocorticoid therapy in patients with idiopathic interstitial pneumonia by high resolution CT semi quantitative score. Methods 32 cases of idiopathic interstitial pneumonia were treated with conventional treatment, combined with glucocorticoids, the use of high resolution CT semi quantitative score, the short-term efficacy of its accurate judgement. Results The analysis shows that high resolution CT semi quantitative score below 20% idiopathic interstitial pneumonia patients with hospital mortality period is only 5.26%, and the high resolution CT semi quantitative score during the high fatality rate of 38.46% hospitalized patients with 20.00% or more, the difference was statistically significant (P<0.05). Conclusion The application of high resolution CT semi quantitative score of received corticosteroid therapy for idiopathic interstitial pneumonia patients with curative effect to give accurate judgment to the doctor for the future development of drug treatment and guarantee its prognosis are of positive significance.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号